File Download
  Links for fulltext
     (May Require Subscription)

Article: Protection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong

TitleProtection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong
Authors
KeywordsAndersen-Gill model
comirnaty
CoronaVac
immunity
Omicron
protective effectiveness
SARS-CoV-2
Issue Date1-Jan-2025
PublisherTaylor and Francis Group
Citation
Expert Review of Vaccines, 2025, v. 24, n. 1, p. 252-260 How to Cite?
Abstract

Background: As the COVID-19 pandemic transitions into its fourth year, understanding the dynamics of immunity is critical for implementing effective public health measures. This study examines vaccine-induced, natural, and hybrid immunity to SARS-CoV-2 in Hong Kong, focusing on their protective effectiveness and waning characteristics against infection during the Omicron BA.1/2 dominant period. Research Design and Methods: We conducted a territory-wide retrospective cohort study using vaccination and infection records from the Hong Kong Department of Health. The analysis included over 6.5 million adults, applying the Andersen-Gill model to estimate protective effectiveness while addressing selection bias through inverse probability weighting. Results: Vaccine-induced immunity peaked one month after the first dose but waned rapidly, while boosters significantly prolonged protection. Infection-induced immunity showed higher initial effectiveness but declined faster than vaccine-induced immunity. Hybrid immunity provided the most durable protection. mRNA vaccines (Comirnaty) demonstrated greater effectiveness and slower waning compared to inactivated vaccines (CoronaVac). Conclusions: Hybrid immunity represents the most effective strategy for sustained protection against SARS-CoV-2. Public health policies should emphasize booster campaigns and hybrid immunity pathways to enhance population-level immunity and guide future COVID-19 management in Hong Kong.


Persistent Identifierhttp://hdl.handle.net/10722/361928
ISSN
2023 Impact Factor: 5.5
2023 SCImago Journal Rankings: 1.412

 

DC FieldValueLanguage
dc.contributor.authorJiang, Jialiang-
dc.contributor.authorLam, Kwok Fai-
dc.contributor.authorLau, Eric Ho Yin-
dc.contributor.authorYin, Guosheng-
dc.contributor.authorLin, Yun-
dc.contributor.authorCowling, Benjamin John-
dc.date.accessioned2025-09-17T00:32:07Z-
dc.date.available2025-09-17T00:32:07Z-
dc.date.issued2025-01-01-
dc.identifier.citationExpert Review of Vaccines, 2025, v. 24, n. 1, p. 252-260-
dc.identifier.issn1476-0584-
dc.identifier.urihttp://hdl.handle.net/10722/361928-
dc.description.abstract<p>Background: As the COVID-19 pandemic transitions into its fourth year, understanding the dynamics of immunity is critical for implementing effective public health measures. This study examines vaccine-induced, natural, and hybrid immunity to SARS-CoV-2 in Hong Kong, focusing on their protective effectiveness and waning characteristics against infection during the Omicron BA.1/2 dominant period. Research Design and Methods: We conducted a territory-wide retrospective cohort study using vaccination and infection records from the Hong Kong Department of Health. The analysis included over 6.5 million adults, applying the Andersen-Gill model to estimate protective effectiveness while addressing selection bias through inverse probability weighting. Results: Vaccine-induced immunity peaked one month after the first dose but waned rapidly, while boosters significantly prolonged protection. Infection-induced immunity showed higher initial effectiveness but declined faster than vaccine-induced immunity. Hybrid immunity provided the most durable protection. mRNA vaccines (Comirnaty) demonstrated greater effectiveness and slower waning compared to inactivated vaccines (CoronaVac). Conclusions: Hybrid immunity represents the most effective strategy for sustained protection against SARS-CoV-2. Public health policies should emphasize booster campaigns and hybrid immunity pathways to enhance population-level immunity and guide future COVID-19 management in Hong Kong.</p>-
dc.languageeng-
dc.publisherTaylor and Francis Group-
dc.relation.ispartofExpert Review of Vaccines-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectAndersen-Gill model-
dc.subjectcomirnaty-
dc.subjectCoronaVac-
dc.subjectimmunity-
dc.subjectOmicron-
dc.subjectprotective effectiveness-
dc.subjectSARS-CoV-2-
dc.titleProtection and waning of vaccine-induced, natural and hybrid immunity to SARS-CoV-2 in Hong Kong-
dc.typeArticle-
dc.description.naturepublished_or_final_version-
dc.identifier.doi10.1080/14760584.2025.2485252-
dc.identifier.pmid40137440-
dc.identifier.scopuseid_2-s2.0-105002567403-
dc.identifier.volume24-
dc.identifier.issue1-
dc.identifier.spage252-
dc.identifier.epage260-
dc.identifier.eissn1744-8395-
dc.identifier.issnl1476-0584-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats